BackgroundCheck.run
Search For

Mark E Gurney, 70910 Rosewood Ave, Grand Rapids, MI 49506

Known as:
Mark Eddy Gurney Mark E Yurko
Related to:
Karen I Sizemore 69

Mark Gurney Phones & Addresses

910 Rosewood Ave, East Grand Rapids, MI 49506    616-4751037   

Grand Rapids, MI   

Vero Beach, FL   

Riverside, IL   

Chicago, IL   

Wyoming, MI   

Work

Position: Professional/Technical

Emails

r***[email protected]
Get Report
Control this profile

Mentions for Mark E Gurney

Mark Gurney resumes & CV records

Resumes

Mark Gurney Photo 47

Chairman And Chief Executive Officer

Location:
Grand Rapids, MI
Industry:
Pharmaceuticals
Work:
Tetra Discovery Partners LLC since Nov 2010
Founder & President West Virginia University since Aug 2012
Adjunct Professor Grand Angels since Nov 2010
Member Michigan Accelerator Fund-1 since Mar 2010
Technical Advisory Board-Life Sciences deCODE genetics 2000 - 2010
Senior Vice President Pharmacia 1995 - 2000
Director, Genomics Research Northwestern University, Feinberg School of Medicine 1989 - 1995
Associate Professor University of Chicago Medical Center 1982 - 1989
Assistant Professor
Education:
Northwestern University - Kellogg School of Management 1990 - 1994
MBA, Business California Institute of Technology 1976 - 1980
PhD, Neuroscience
Skills:
Biotechnology, Drug Discovery, Clinical Development, Clinical Trials, Drug Development, Lifesciences, Genomics, Life Sciences, Pharmaceutical Industry, Neuroscience, Biochemistry, Commercialization, Technology Transfer, Entrepreneurship, Oncology, R&D, Molecular Biology, Genetics, Pharmacology, Analytical Chemistry, Start Ups, Cell, Science, Medicinal Chemistry, Chemistry, Protein Chemistry, Cancer, Infectious Diseases, Regulatory Affairs
Mark Gurney Photo 48

Mark Gurney

Mark Gurney Photo 49

Mark Gurney

Mark Gurney Photo 50

Senior Vice President At Decode Genetics

Location:
Greater Grand Rapids, Michigan Area
Industry:
Pharmaceuticals

Publications & IP owners

Us Patents

Alzheimers Disease Secretase, App Substrates Therefor, And Uses Therefor

US Patent:
6440698, Aug 27, 2002
Filed:
Apr 12, 2000
Appl. No.:
09/548367
Inventors:
Mark E. Gurney - Grand Rapids MI, 49506
Michael J. Bienkowski - Portage MI, 49024
Robert L. Heinrikson - Plainwell MI, 49080
Luis A. Parodi - S-11543 Stockholm, SE
Riqiang Yan - Kalamazoo MI, 49009
International Classification:
C12P 2106
US Classification:
435 691, 4352523, 435325, 4353201, 536 231
Abstract:
The present invention provides the enzyme and enzymatic procedures for cleaving the secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associated nucleic acids, peptides, vectors, cells, and cell isolates, and assays that are particularly useful for identifying candidate therapeutics for treatment or prevention of Alzheimers disease.

Aspartyl Protease 2 (Asp2) Antisense Oligonucleotides

US Patent:
6500667, Dec 31, 2002
Filed:
Apr 18, 2000
Appl. No.:
09/551853
Inventors:
Mark E. Gurney - Grand Rapids MI
Michael J. Bienkowski - Portage MI
Robert L. Heinrikson - Plainwell MI
Luis A. Parodi - Stockholm, SE
Riqiang Yan - Kalamazoo MI
Assignee:
Pharmacia Upjohn Company - Kalamazoo MI
International Classification:
C12N 500
US Classification:
435375, 536 231, 536 241, 536 245, 514 44
Abstract:
The present invention provides the enzyme and enzymatic procedures for cleaving the secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associated nucleic acids, peptides, vectors, cells, and cell isolates, and assays that are particularly useful for identifying candidate therapeutics for treatment or prevention of Alzheimers disease.

Human Sel-10 Polypeptides And Polynucleotides That Encode Them

US Patent:
6638731, Oct 28, 2003
Filed:
Dec 17, 1998
Appl. No.:
09/213888
Inventors:
Mark E. Gurney - Grand Rapids MI
Adele M. Pauley - Plainwell MI
Jinhe Li - Kalamazoo MI
Assignee:
Pharmacia and Upjohn Company - Kalamazoo MI
International Classification:
C12P 2106
US Classification:
435 691, 4352523, 4353201, 536 231
Abstract:
The present invention provides isolated nucleic acid molecules comprising a polynucleotide encoding either of two alternative splice variants of human sel-10, one of which is expressed in hippocampal cells, and one of which is expressed in mammary cells. The invention also provides isolated sel-10 polypeptides and cell lines which express them in which A processing is altered.

Alzheimers Disease Secretase, App Substrates Therefor, And Uses Therefor

US Patent:
6699671, Mar 2, 2004
Filed:
Oct 13, 1999
Appl. No.:
09/416901
Inventors:
Mark E. Gurney - Grand Rapids MI
Michael J. Bienkowski - Portage MI
Robert L. Heinrikson - Plainwell MI
Luis A. Parodi - Stockholm, SE
Riqiang Yan - Kalamazoo MI
Assignee:
Pharmacia Upjohn Company - Kalamazoo MI
International Classification:
G01N 3353
US Classification:
435 71, 530350, 530300
Abstract:
The present invention provides the enzyme and enzymatic procedures for cleaving the secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associated nucleic acids, peptides, vectors, cells, and cell isolates, and assays that are particularly useful for identifying candidate therapeutics for treatment or prevention of Alzheimers disease.

Method Of Identifying Agents That Inhibit App Processing Activity

US Patent:
6706485, Mar 16, 2004
Filed:
Apr 12, 2000
Appl. No.:
09/548376
Inventors:
Mark E. Gurney - Grand Rapids MI
Michael J. Bienkowski - Portage MI
Robert L. Heinrikson - Plainwell MI
Luis A. Parodi - Stockkholm, SE
Riqiang Yan - Kalamazoo MI
Assignee:
Pharmacia Upjohn Company - Kalamazoo MI
International Classification:
G01N 3353
US Classification:
435 71, 435183, 435195, 435212, 435 691, 4353201, 536 231, 536 234, 536 235, 530300, 530350
Abstract:
The present invention provides methods of identifying agents that inhibit the amyloid precursor protein (APP) processing activity of Asp2 polypeptide.

Alzheimers Disease Secretase, App Substrates Therefor, And Uses Therefor

US Patent:
6727074, Apr 27, 2004
Filed:
Feb 27, 2001
Appl. No.:
09/794927
Inventors:
Mark E. Gurney - Grand Rapids MI
Michael J. Bienkowski - Portage MI
Robert L. Heinrikson - Plainwell MI
Luis A. Parodi - Stockholm, SE
Riqiang Yan - Kalamazoo MI
Assignee:
Pharmacia Upjohn Company - Kalamazoo MI
International Classification:
C12Q 137
US Classification:
435 24, 435 23, 435135, 435212, 530350, 424450
Abstract:
The present invention provides the enzyme and enzymatic procedures for cleaving the secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associated nucleic acids, peptides, vectors, cells, and cell isolates, and assays that are particularly useful for identifying candidate therapeutics for treatment or prevention of Alzheimers disease.

Human Sel-10 Polypeptides And Polynucleotides That Encode Them

US Patent:
6730778, May 4, 2004
Filed:
Jun 9, 1999
Appl. No.:
09/328877
Inventors:
Mark E. Gurney - Grand Rapids MI
Adele M. Pauley - Plainwell MI
Jinhe Li - Kalamazoo MI
Assignee:
Pharmacia and Upjohn Company - Kalamazoo MI
International Classification:
C07K 1700
US Classification:
530350, 530300
Abstract:
The present invention provides isolated nucleic acid molecules comprising a polynucleotide encoding either of two alternative splice variants of human sel-10, one of which is expressed in hippocampal cells, and one of which is expressed in mammary cells. The invention also provides isolated sel-10 polypeptides and cell lines which express them in which A processing is altered.

Alzheimers Disease Secretase, App Substrates Therefor, And Uses Thereof

US Patent:
6737510, May 18, 2004
Filed:
Apr 12, 2000
Appl. No.:
09/548373
Inventors:
Mark E. Gurney - Grand Rapids MI
Michael J. Bienkowski - Portage MI
Robert L. Heinrikson - Plainwell MI
Luis A. Parodi - Stockholm, SE
Riqiang Yan - Kalamazoo MI
Assignee:
Pharmacia Upjohn Company - Kalamazoo MI
International Classification:
C07K 1700
US Classification:
530350, 435219
Abstract:
The present invention provides the enzyme and enzymatic procedures for cleaving the secretase cleavage site of the APP protein and associated nucleic acids, peptides, vectors, cells and cell isolates and assays. The invention further provides a modified APP protein and associated nucleic acids, peptides, vectors, cells, and cell isolates, and assays that are particularly useful for identifying candidate therapeutics for treatment or prevention of Alzheimers disease.

Possible Relatives

David D Gurney  Dale M Gurney  Debra Gurney  Daniel C Gurney  Aaron L Gurney  Denis M Gurney  Dennis A Gurney  Mark W Johnson  Mark E Stamps  Mark Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.